24
Participants
Start Date
October 27, 2020
Primary Completion Date
December 9, 2020
Study Completion Date
December 9, 2020
Reference drug
1 Cap., single oral administration under fed condition
Test drug 1
1 Tab., single oral administration under fed condition
Test drug 2
1 Tab., single oral administration under fed condition
Central Hospital, Gyeonggi-do
Lead Sponsor
Chong Kun Dang Pharmaceutical
INDUSTRY